| |
| |
|
| Insider
Information: |
Clemens Peter A |
| Relationship: |
Senior VP & CFO |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
545,430 |
|
|
Indirect Shares
|
3,605 |
|
|
| Direct
Value |
$2,236 |
|
|
|
Indirect Value
|
$15 |
|
|
| Total
Shares |
549,035 |
|
|
| Total
Value |
$2,251 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acura Pharmaceuticals Inc |
ACUR |
Senior VP & CFO |
2023-11-20 |
545,430 |
2014-05-16 |
3,605 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP & CFO |
• – – |
2023-11-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
40,000 |
545,430 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP & CFO |
• – – |
2023-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
40,000 |
505,430 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP & CFO |
• – – |
2022-08-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
49,333 |
465,430 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP & CFO |
• – – |
2021-02-24 |
4 |
D |
$0.40 |
$6,040 |
D/D |
(15,100) |
416,097 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP & CFO |
• – – |
2021-02-24 |
4 |
OE |
$0.15 |
$6,040 |
D/D |
40,000 |
431,197 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP & CFO |
• – – |
2021-01-04 |
4 |
D |
$0.21 |
$4,098 |
D/D |
(19,514) |
391,197 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP & CFO |
• – – |
2021-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
49,334 |
410,711 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP & CFO |
• – – |
2020-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,334 |
364,467 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP & CFO |
• – – |
2020-01-02 |
4 |
D |
$0.23 |
$711 |
D/D |
(3,090) |
361,377 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP and CFO |
• – – |
2017-12-14 |
4 |
B |
$0.10 |
$30,000 |
D/D |
300,000 |
355,182 |
2.74 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP and CFO |
• – – |
2014-05-16 |
4/A |
B |
$1.21 |
$3,621 |
D/D |
3,000 |
275,918 |
2.66 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP and CFO |
• – – |
2014-05-16 |
4 |
S |
$1.21 |
$3,621 |
D/D |
(3,000) |
275,918 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP and CFO |
• – – |
2014-02-27 |
4 |
D |
$2.03 |
$13,981 |
D/D |
(6,887) |
272,913 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP and CFO |
• – – |
2014-02-27 |
4 |
OE |
$1.30 |
$12,188 |
D/D |
9,375 |
279,800 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP and CFO |
• – – |
2014-01-01 |
4 |
D |
$1.67 |
$96,010 |
D/D |
(57,491) |
270,425 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP and CFO |
• – – |
2013-12-17 |
4 |
D |
$1.54 |
$12,582 |
D/D |
(8,170) |
327,471 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP and CFO |
• – – |
2013-12-17 |
4 |
OE |
$1.30 |
$12,188 |
D/D |
9,375 |
335,641 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP and CFO |
• – – |
2012-01-01 |
4 |
D |
$2.22 |
$115,049 |
D/D |
(51,824) |
326,266 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP and CFO |
• – – |
2012-01-01 |
4 |
D |
$3.49 |
$192,795 |
D/D |
(55,242) |
388,090 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP and CFO |
• – – |
2012-01-01 |
4 |
OE |
$1.30 |
$12,188 |
D/D |
9,375 |
443,782 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP and CFO |
• – – |
2011-08-15 |
4/A |
B |
$2.68 |
$5,360 |
D/D |
2,000 |
434,407 |
2.74 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP and CFO |
• – – |
2011-08-15 |
4 |
B |
$2.68 |
$6,700 |
D/D |
2,500 |
434,907 |
2.74 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP and CFO |
• – – |
2011-08-12 |
4 |
B |
$2.65 |
$2,650 |
I/I |
1,000 |
3,605 |
1.91 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP and CFO |
• – – |
2011-01-26 |
4 |
B |
$2.98 |
$1,043 |
I/I |
350 |
2,605 |
1.91 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
Senior VP and CFO |
• – – |
2011-01-25 |
4 |
OE |
$1.30 |
$12,188 |
D/D |
9,375 |
437,187 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
